115 related articles for article (PubMed ID: 37290325)
1. Aspirin induces immunogenic cell death and enhances cancer immunotherapy in colorectal cancer.
Lei J; Zhou Z; Fang J; Sun Z; He M; He B; Chen Q; Paek C; Chen P; Zhou J; Wang H; Tang M; Yin L; Chen Y
Int Immunopharmacol; 2023 Aug; 121():110350. PubMed ID: 37290325
[TBL] [Abstract][Full Text] [Related]
2. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phospholipase D1 induces immunogenic cell death and potentiates cancer immunotherapy in colorectal cancer.
Hwang WC; Song D; Lee H; Oh C; Lim SH; Bae HJ; Kim ND; Han G; Min DS
Exp Mol Med; 2022 Sep; 54(9):1563-1576. PubMed ID: 36131027
[TBL] [Abstract][Full Text] [Related]
4. 4-(N)-Docosahexaenoyl 2', 2'-difluorodeoxycytidine induces immunogenic cell death in colon and pancreatic carcinoma models as a single agent.
Hufnagel S; Xu H; Colemam MF; Valdes SA; Liu KA; Hursting SD; Cui Z
Cancer Chemother Pharmacol; 2022 Jan; 89(1):59-69. PubMed ID: 34698902
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.
Wang D; Jiang W; Zhu F; Mao X; Agrawal S
Int J Oncol; 2018 Sep; 53(3):1193-1203. PubMed ID: 29956749
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of CT26 murine tumors is characterized by an oligoclonal response of tissue-resident memory T cells against the AH1 rejection antigen.
Stringhini M; Probst P; Neri D
Eur J Immunol; 2020 Oct; 50(10):1591-1597. PubMed ID: 32470143
[TBL] [Abstract][Full Text] [Related]
7. In Situ Vaccination with Mitochondria-Targeting Immunogenic Death Inducer Elicits CD8
Wang Y; Wang W; Gu R; Chen J; Chen Q; Lin T; Wu J; Hu Y; Yuan A
Adv Sci (Weinh); 2023 Jul; 10(20):e2300286. PubMed ID: 37127892
[TBL] [Abstract][Full Text] [Related]
8. Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death.
Qin J; Kunda N; Qiao G; Calata JF; Pardiwala K; Prabhakar BS; Maker AV
Cell Death Dis; 2017 Feb; 8(2):e2584. PubMed ID: 28151483
[TBL] [Abstract][Full Text] [Related]
9. Curcumin Enhanced Ionizing Radiation-Induced Immunogenic Cell Death in Glioma Cells through Endoplasmic Reticulum Stress Signaling Pathways.
Xiu Z; Sun T; Yang Y; He Y; Yang S; Xue X; Yang W
Oxid Med Cell Longev; 2022; 2022():5424411. PubMed ID: 36238646
[TBL] [Abstract][Full Text] [Related]
10. An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer.
Wang L; Guan R; Xie L; Liao X; Xiong K; Rees TW; Chen Y; Ji L; Chao H
Angew Chem Int Ed Engl; 2021 Feb; 60(9):4657-4665. PubMed ID: 33217194
[TBL] [Abstract][Full Text] [Related]
11. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
Jafari S; Lavasanifar A; Hejazi MS; Maleki-Dizaji N; Mesgari M; Molavi O
Daru; 2020 Jun; 28(1):159-169. PubMed ID: 31942696
[TBL] [Abstract][Full Text] [Related]
12. Oleandrin, a cardiac glycoside, induces immunogenic cell death via the PERK/elF2α/ATF4/CHOP pathway in breast cancer.
Li X; Zheng J; Chen S; Meng FD; Ning J; Sun SL
Cell Death Dis; 2021 Mar; 12(4):314. PubMed ID: 33762577
[TBL] [Abstract][Full Text] [Related]
13. Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate.
You SY; Rui W; Chen ST; Chen HC; Liu XW; Huang J; Chen HY
Biochem Biophys Res Commun; 2019 Jun; 513(4):891-897. PubMed ID: 31003768
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of three commercial photosensitizers for efficiency of inducing immunogenic cell death in anti-tumor immunotherapy].
Lin X; Mao D; Bai R
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1791-1798. PubMed ID: 36651246
[TBL] [Abstract][Full Text] [Related]
15. Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.
Wang Z; Chen L; Ma Y; Li X; Hu A; Wang H; Wang W; Li X; Tian B; Dong J
J Nanobiotechnology; 2021 Aug; 19(1):243. PubMed ID: 34384429
[TBL] [Abstract][Full Text] [Related]
16. FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer.
Lu L; Jiang YX; Liu XX; Jin JM; Gu WJ; Luan X; Guan YY; Zhang LJ
Oncoimmunology; 2023; 12(1):2217024. PubMed ID: 37261088
[TBL] [Abstract][Full Text] [Related]
17. CDK12/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer.
Li Y; Zhang H; Li Q; Zou P; Huang X; Wu C; Tan L
Cancer Lett; 2020 Dec; 495():12-21. PubMed ID: 32941949
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases.
Olino K; Wada S; Edil BH; Pan X; Meckel K; Weber W; Slansky J; Tamada K; Lauer P; Brockstedt D; Pardoll D; Schulick R; Yoshimura K
Ann Surg Oncol; 2012 Jul; 19 Suppl 3(Suppl 3):S597-607. PubMed ID: 21979110
[TBL] [Abstract][Full Text] [Related]
19. Cellular cytotoxicity is a form of immunogenic cell death.
Minute L; Teijeira A; Sanchez-Paulete AR; Ochoa MC; Alvarez M; Otano I; Etxeberrria I; Bolaños E; Azpilikueta A; Garasa S; Casares N; Perez Gracia JL; Rodriguez-Ruiz ME; Berraondo P; Melero I
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217765
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]